Wednesday, September 16, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP InternationalTrade Show
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP InternationalTrade Show
Fiinews
No Result
View All Result
Home Markets

Market: Pharma contract manufacturing to grow at 13.3% CAGR

Fiinews by Fiinews
October 20, 2022
in Markets
Reading Time: 2 mins read
A A
0
Aurobindo
0
SHARES
12
VIEWS
LinkedinShare on Twitter

Manufacturing edge: 58 companies are certified by US FDA, WHO, MCC and MHRA

The Indian pharmaceutical contract manufacturing market is anticipated to grow at a favourable CAGR of around 13.3% during 2022-28, as India, being one of the free trade agreement members, holds the access to the best established and emerging pharmaceutical markets in the Asia-Pacific region.

Due to the favorable factors, such as low manufacturing cost, easy availability of skilled workers, and well-established certified plants, the Indian pharmaceutical contract manufacturing has witnessed higher growth, said the report “Indian Pharmaceutical Contract Manufacturing Market Research and Forecast 2022-2028”.

Nearly 58 companies have certification including Emcure Pharmaceuticals Ltd which is certified with US FDA, WHO, Medical Control Council (MCC) and the Medicine and Healthcare products Regulatory Authority of the United Kingdom, according to the report released on 19 Oct 2022.

In basic manufacturing of medical drugs and devices, India has a superior edge over nations, such as Vietnam, China and Ireland, owing to the availability of immense raw material, technical workforce and WHO-approved production premises.

During the COVID-19 pandemic, several initiatives were taken by the Union Cabinet to boost the Indian pharmaceutical industry, which includes the amendment of the existing foreign direct investment (FDI), which allows the foreign investors to invest up to 100% under the automatic route for manufacturing medical devices.

With the advent of global pharmaceutical organizations, and their vast presence in India, the concept of contract manufacturing has steadily evolved, which in turn boosts the growth of India’s pharmaceutical contract manufacturing market, said the report.

Leading companies in the sector are:

Agrata Biotech Ltd

Ankur Drugs and Pharma Ltd

Aurobindo Pharma

BDR Pharmaceuticals Internationals Pvt Ltd

Ceegolabs Pvt Ltd

Ciron Drugs & Pharmaceuticals Pvt Ltd

Contract Pharmaceuticals Ltd

Cosway Biosciences

Cubic Lifesciences Pvt Ltd

Daffohils Laboratories Pvt Ltd. fiinews.com

Tags: ResearchAndMarkets
ShareTweetShare

Related Posts

E3 logo
Markets

Market: E3 signs lithium MoU with Mumbai Epsilon

by Fiinews
September 15, 2026
0
16

Handa says electric mobility growth requires battery materials E3 LITHIUM LTD (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), "E3", a leader...

ABB India
Markets

Market: ABB launches AquaMaster+

by Fiinews
September 15, 2026
0
15

Pressure mounting on water resources globally to prevent losses in the distribution system, says Raghu Kumar ABB has launched AquaMaster+™,...

IFAT India

Market: India needs policy to projects translation

September 15, 2026
14
FICCI

Market: EAM wants BRICS incubator-startup fund

September 15, 2026
18
PIB

Market: Non-tariff barriers talked at BRICS Forum

September 15, 2026
28
PIB

Market: PM calls for more connected BRICS

September 14, 2026
21
SBI YONO
Upits 2026 brochure 062026 pdf

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Investment: India welcomes US investment and technology collaboration

    0 shares
    Share 0 Tweet 0
  • Market: PM Modi-President Zelenskyy discussed trade and technology

    0 shares
    Share 0 Tweet 0
  • Manufacturing: Approved ‘BioE3’of Biotechnology Dept

    0 shares
    Share 0 Tweet 0
  • Technology: Mastercard-supported Digital Saksham trains Maharashtran MSMEs

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Market: E3 signs lithium MoU with Mumbai Epsilon
  • Manufacture: Teradyne committed to Indian markets
  • Manufacture: Omkam to assemble Russian aircraft
  • Market: ABB launches AquaMaster+
  • Market: India needs policy to projects translation

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP International

© 2024 FIINEWS - Design and developed by 7clicksmedia.